Celanese Corporation Common Stock (CE) — Analysis Summary
Celanese Corporation Common Stock (CE) has a market cap of $5.26B with year-over-year revenue growth of -7.2%. Net margin stands at -12.2%. The stock trades at a P/E ratio of -4.8.
Key Takeaways
- Revenue changed -7.2% year-over-year
- Net margin of -12.2%
- P/E ratio of -4.8
Compared to other companies in the PLASTIC MATERIAL, SYNTH RESIN/RUBBER, CELLULOS (NO GLASS) sector, CE posted revenue growth of -7.2% and trades at a P/E of -4.8.
Celanese Corporation Common Stock (CE)
UPDATED — ET · SOURCE POLYGON
Red Flags & WarningsHigh Risk Signals
Multiple material red flags are active and deserve closer underwriting before relying on any valuation output.
Debt/EBITDA at 307.3x — highly leveraged, potential refinancing risk
Interest coverage at -1.0x — earnings do not cover interest payments
Celanese is one of the world's largest producers of acetic acid and its downstream derivative chemicals, which are used in various end markets, including coatings and adhesives. The company is also one of the largest producers of specialty polymers, which are used in the automotive, electronics, medical, building, and consumer end markets. The company also makes cellulose derivatives used in cigarette filters.
Sector
PLASTIC MATERIAL, SYNTH RESIN/RUBBER, CELLULOS (NO GLASS)
Employees
11,434
Headquarters
IRVING, TX
Exchange
XNYS
Systematic competitive advantage assessment based on 4yr data
This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.
First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.
Capital Structure
Cash Flow
Annual Dividend/Share
$0.12
Dividend Yield
0.25%
Dividend History
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.